Skip to content

Drug interactions

Bimekizumab + Warfarin

Severity: Moderate

Bimekizumab and Warfarin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Inhibition of IL-17 can reverse cytokine-mediated suppression of CYP enzymes, potentially altering the metabolism of narrow therapeutic index drugs. For warfarin this may change the INR when bimekizumab is started or stopped.

What this interaction means in plain words

Bimekizumab and Warfarin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bimekizumab belongs to Miscellaneous; Warfarin belongs to Cardiovascular.

Evidence level: Low

Why it happens

Normalization of cytokine-suppressed CYP450 expression may change warfarin clearance.

What to do

Check INR more frequently after starting or stopping bimekizumab. Adjust the warfarin dose according to INR.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bimekizumab and Warfarin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bimekizumab with Warfarin?

MediHelp rates the interaction as moderate. Bimekizumab and Warfarin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Inhibition of IL-17 can reverse cytokine-mediated suppression of CYP enzymes, potentially altering the metabolism of narrow therapeutic index drugs. For warfarin this may change the INR when bimekizumab is started or stopped.

How serious is the interaction between Bimekizumab and Warfarin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check INR more frequently after starting or stopping bimekizumab. Adjust the warfarin dose according to INR.

What other medicines interact with Bimekizumab?

MediHelp also lists interactions of Bimekizumab with, for example, Cyclosporin. The full list is on the Bimekizumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in